Is the worst over for equity markets? Should you increase exposure to equity markets? Find out in this report.
This index fund lets you buy into the Indian market and make the most of the correction!
Find out why we think you should lock into your gains on this Prime Stock!
Successful execution of a new strategy could prove to be rewarding for shareholders. Find out more in the report!
A sharp correction despite fundamentals remaining intact in the case of this Prime Stock!
As Indian markets declined, we’ve consistently recommended stocks to strategically average as well as new ones to add to your portfolio. Simultaneously, we’ve looked beyond
How to filter out unnecessary market information to build wealth
Find out why this stock is making its way into our BUY list for the second time!
When will your SIPs turn a corner if you keep them running through a challenging period like now?
With Trump’s talk of tariffs dominating headlines, if you too have joined in the quest for stocks that may offer immunity from this threat then this vaccine-maker is one of our picks – Glaxosmithkline Pharmaceuticals Limited. This MNC pharma player has an enduring suite of brands that have withstood challenges, such as the advent of […]
Results update for 13 of our Prime Stocks.
Is the MSCI India Index a better option than the Nifty50, Nifty100 or Nifty LargeMidcap 250? Find out here!
Hold On
You are being redirected to another page,
Elevate Your Wealth with Professional Portfolio Management
